Skip to main content
Sign In

Clinical and Laboratory Research

Alzheimer’s disease is the sixth leading cause of death in the US, affecting more than 5 million Americans. At the current pace and without an obvious cure or medical breakthrough on the horizon, the number of Americans diagnosed with AD will triple to almost 13.8 million by 2050. At the Rocky Mountain Alzheimer’s Disease Center (RMADC), we combine innovative laboratory and clinical research with world-class clinical care in our efforts to help improve the lives of people with Alzheimer’s disease and their families. Here, we provide a snapshot of some of our ongoing laboratory research projects.